Hypertension:

Indications for: BYSTOLIC

Hypertension.

Adult Dosage:

≥18yrs: initially 5mg once daily. Individualize; may increase at 2-week intervals; max 40mg/day. Severe renal or moderate hepatic impairment: initially 2.5mg once daily.

Children Dosage:

<18yrs: not recommended.

BYSTOLIC Contraindications:

Severe hepatic impairment (Child-Pugh >B). Severe bradycardia. 2nd- or 3rd-degree AV block. Cardiogenic shock. Overt heart failure. Sick sinus syndrome (unless paced).

BYSTOLIC Warnings/Precautions:

CHF. Angina. Recent MI. Bronchospastic disease. Diabetes. Hyperthyroidism. Severe renal impairment. Moderate hepatic impairment. Avoid abrupt cessation (taper over 1–2 weeks). Surgery. Peripheral vascular disease. Pheochromocytoma. Pregnancy (Cat.C). Nursing mothers: not recommended.

BYSTOLIC Classification:

Cardioselective beta-blocker.

BYSTOLIC Interactions:

Caution with phenylalkylamine and benzothiazepine calcium channel blockers (eg, verapamil, diltiazem), antiarrhythmics (eg, disopyramide), digoxin, reserpine, guanethidine; monitor. May be potentiated by CYP2D6 inhibitors (eg, quinidine, propafenone, paroxetine, fluoxetine); may need to reduce dose. If on both nebivolol and clonidine, discontinue nebivolol before tapering clonidine. May block epinephrine.

Adverse Reactions:

Headache, fatigue, dizziness, GI upset.

Metabolism:

Hepatic.

Drug Elimination:

Renal (38%); fecal (44%). Half-life: ~12hrs.

How Supplied:

Tabs—30, 100